GlassScriptPhysician profile
Neeraj Jain
NPI 1992728935
$2,900.16
in general payments reported to CMS, 2019-2025
20 companies · $779 in 2025
The $779 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $584 · 2020: $202 · 2021: $201 · 2022: $211 · 2023: $498 · 2024: $426 · 2025: $779.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,674 · Travel and Lodging: $29.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,673.67 |
| Travel and Lodging | $29.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $425.44 | 2019-2025 | Lifevest |
| Abbott Laboratories | $413.91 | 2019-2025 | Mitraclip, Proclaim |
| Amgen INC. | $334.76 | 2019-2024 | Repatha |
| Astrazeneca Pharmaceuticals LP | $201.20 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $200.68 | 2019-2021 | |
| Recor Medical INC | $159.17 | 2025 | Paradise Ultrasound Renal Denervation System |
| Shockwave Medical, INC | $143.66 | 2025 | |
| Kestra Medical Technology Services, INC. | $122.69 | 2022 | |
| Janssen Scientific Affairs, LLC | $113.71 | 2024 | Xarelto |
| Janssen Pharmaceuticals, INC | $112.41 | 2019-2024 | Xarelto |
| Itamar Medical INC | $103.73 | 2023 | Watchpatone |
| Abiomed | $99.99 | 2025 | |
| Ge Healthcare | $94.54 | 2020-2025 | |
| Atricure, INC. | $92.06 | 2023-2025 | Synergy Ablation System |
| Pfizer INC. | $90.74 | 2022-2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $76.39 | 2025 | Evoque |
| Novartis Pharmaceuticals Corporation | $44.22 | 2022-2023 | |
| Medtronic, INC. | $33.27 | 2022 | |
| Exact Sciences Corporation | $19.88 | 2025 | The Cologuard Plus Collection Kit |
| Merck Sharp & Dohme LLC | $17.71 | 2023 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neeraj Jain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.